A Noval Established Cuproptosis-Associated LncRNA Signature for Prognosis Prediction in Primary Hepatic Carcinoma

Figure 4

The high-risk and low-risk groups are analyzed using (a) the whole gene set, (b) the cuproptosis gene set, (c) the cuproptosis lncRNA set, and (d) the cuproptosis risk lncRNA set.

(a)

(b)

(c)

(d)